Literature DB >> 28118086

A plant protein signal sequence improved humoral immune response to HPV prophylactic and therapeutic DNA vaccines.

Silvia Massa1, Francesca Paolini2, Gianfranca Curzio2, Marcelo Nazario Cordeiro3, Elena Illiano4,5, Olivia Costantina Demurtas1, Rosella Franconi5, Aldo Venuti2.   

Abstract

Signal sequences (ss) play a critical role in the sorting of nascent secretory and membrane proteins. This function has been conserved from bacteria through eukaryotes, although ss appear diverse in length and amino acid composition. Sorting of proteins is also critical to instruct antigens for a proper immunological response. Thus, a plant ss was used to drive Human Papillomavirus (HPV) model antigens into the human secretory pathway: the HPV16 E7 oncoprotein, its chimera with the coat protein (CP) of the Potato Virus X (PVX), the first 200 amino acids of the HPV16 minor capsid protein L2 (known to harbour cross-reacting epitopes) and its chimera with E7 gene. These genes were used to transfect HEK-293 cells and to immunize C57BL/6 mice. The ss-provided genes were expressed, and proteins detected by immunofluorescence and immunoblotting. Mouse immunization with DNA constructs carrying the ss elicited a strong humoral response against both E7 and L2 and a weak cell-mediated immunity. To our knowledge this is the first demonstration that a signal sequence derived from a plant can modulate the sorting of a heterologous protein in mammalian cells. This activity in mammalian cells may be responsible for the observed increased humoral response to DNA-based vaccines that are generally weak inducers of IgG response. This might open new perspectives in the design of DNA vaccines, especially to counteract infections where a strong humoral response is needed.

Entities:  

Keywords:  HPV; humoral immune response; infectious diseases; plant signal sequences; vaccines

Mesh:

Substances:

Year:  2017        PMID: 28118086      PMCID: PMC5328226          DOI: 10.1080/21645515.2017.1264766

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

Review 1.  Plant-derived vaccines and other therapeutics produced in contained systems.

Authors:  Rosella Franconi; Olivia Costantina Demurtas; Silvia Massa
Journal:  Expert Rev Vaccines       Date:  2010-08       Impact factor: 5.217

Review 2.  The signal peptide.

Authors:  G von Heijne
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

3.  Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.

Authors:  K F Hsu; C F Hung; W F Cheng; L He; L A Slater; M Ling; T C Wu
Journal:  Gene Ther       Date:  2001-03       Impact factor: 5.250

Review 4.  HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.

Authors:  Luciano Mariani; Aldo Venuti
Journal:  J Transl Med       Date:  2010-10-27       Impact factor: 5.531

5.  DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.

Authors:  Lindsey Low; Ann Mander; Katy McCann; David Dearnaley; Torunn Tjelle; Iacob Mathiesen; Freda Stevenson; Christian H Ottensmeier
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

6.  Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein.

Authors:  Silvia Massa; Paola Simeone; Antonio Muller; Eugenio Benvenuto; Aldo Venuti; Rosella Franconi
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

7.  Cloning and characterization of the gene encoding the endopolygalacturonase-inhibiting protein (PGIP) of Phaseolus vulgaris L.

Authors:  P Toubart; A Desiderio; G Salvi; F Cervone; L Daroda; G De Lorenzo
Journal:  Plant J       Date:  1992-05       Impact factor: 6.417

8.  Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.

Authors:  Daning Wang; Zhihai Li; Jieqiong Xiao; Junqi Wang; Li Zhang; Yajing Liu; Fei Fan; Lu Xin; Minxi Wei; Zhibo Kong; Hai Yu; Ying Gu; Jun Zhang; Shaowei Li; Ningshao Xia
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 9.  Emerging biological treatments for uterine cervical carcinoma.

Authors:  Patrizia Vici; Luciano Mariani; Laura Pizzuti; Domenico Sergi; Luigi Di Lauro; Enrico Vizza; Federica Tomao; Silverio Tomao; Emanuela Mancini; Cristina Vincenzoni; Maddalena Barba; Marcello Maugeri-Saccà; Giuseppe Giovinazzo; Aldo Venuti
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

10.  Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids.

Authors:  Gülin Güler-Gane; Sara Kidd; Sudharsan Sridharan; Tristan J Vaughan; Trevor C I Wilkinson; Natalie J Tigue
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more
  10 in total

1.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

2.  Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.

Authors:  Jairo A Fonseca; Jessica N McCaffery; Juan Caceres; Elena Kashentseva; Balwan Singh; Igor P Dmitriev; David T Curiel; Alberto Moreno
Journal:  Vaccine       Date:  2018-04-12       Impact factor: 3.641

Review 3.  Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.

Authors:  Zhigang Zhang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein.

Authors:  Susanna Falcucci; Francesca Paolini; Anna Maria Mileo; Rosella Franconi; Silvia Massa; Antonio Rinaldi; Aldo Venuti
Journal:  ACS Omega       Date:  2021-03-26

5.  Vaccines against Infectious Diseases and Cancer.

Authors:  Ângela Sousa; Christiane P Soares; Aldo Venuti
Journal:  Vaccines (Basel)       Date:  2022-04-20

6.  Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Authors:  Dylan Sheerin; Christina Dold; Laura Silva-Reyes; Aline Linder; Andrew J Pollard; Christine S Rollier
Journal:  Cell Biosci       Date:  2022-06-11       Impact factor: 9.584

7.  A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.

Authors:  Young Chul Park; Yung Taek Ouh; Moon Hee Sung; Hong Gyu Park; Tae Jin Kim; Chi Heum Cho; Jong Sup Park; Jae Kwan Lee
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

8.  Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.

Authors:  Ping Yang; Youqin Ruan; Zhiling Yan; Yang Gao; Hongying Yang; Shaojia Wang
Journal:  BMC Cancer       Date:  2021-11-16       Impact factor: 4.430

Review 9.  Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis.

Authors:  Sedigheh Taghinezhad-S; Hossein Keyvani; Luis G Bermúdez-Humarán; Gilbert G G Donders; Xiangsheng Fu; Amir Hossein Mohseni
Journal:  Cell Mol Life Sci       Date:  2020-09-26       Impact factor: 9.261

10.  The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia.

Authors:  Lin Mu; Jing-Rui Miao; Jing-Hui Song
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.